Skip to main content
American heart journal
Corrigendum to "Assessing cardiac safety in oncology drug development" [Am Heart J 214 (2019) 125-133].
Sex-specific cardiac phenotype and clinical outcomes in patients with hypertrophic cardiomyopathy.
Financial strain and ideal cardiovascular health in middle-aged and older women: Data from the Women's health study.
Assessing cardiac safety in oncology drug development.
Safety profile and utility of treadmill exercise in patients with high-gradient hypertrophic cardiomyopathy.
Design and rationale of a randomized noninferiority trial to evaluate the SurVeil drug-coated balloon in subjects with stenotic lesions of the femoropopliteal artery - the TRANSCEND study.
Association between neighborhood-level socioeconomic deprivation and incident hypertension: A longitudinal analysis of data from the Dallas heart study.
Evolving from volume to value, or to a bolder vision of reimbursement reform?
Funding source and author affiliation in TASER research are strongly associated with a conclusion of device safety.
Characteristics of sudden arrhythmic death in a diverse, urban community.
